Page 1211 - Williams Hematology ( PDFDrive )

1186 Part IX: Lymphocytes and Plasma Cells Chapter 76: Functions of T Lymphocytes: T-cell Receptors for Antigen 1187

in the redistribution of TCRs, costimulation, and accessory molecules 24. Macian F: NFAT proteins: Key regulators of T-cell development and function. Nat Rev
into the region beneath the T-cell:APC contact site. These molecules Immunol 5:472–484, 2005.
128
are segregated into central (cSMAC), peripheral (pSMAC) and distal 25. Devine L, Kieffer LJ, Aitken V, Kavathas PB: Human CD8β, but not mouse CD8β, can
be expressed in the absence of CD8α as a ββ homodimer. J Immunol 164:833–838, 2000.
(dSMAC) supramolecular activation clusters (SMACs). The cSMAC 26. Zhu C, Jiang N, Huang J, et al: Insights from in situ analysis of TCR–pMHC recogni-
contains a concentration of TCR:CD3:peptide:MHC complexes, tion: Response of an interaction network. Immunol Rev 251:49–64, 2013.
costimulatory molecules such as CD28, and signaling molecules such 27. Gao GF, Rao Z, Bell JI: Molecular coordination of αβ T-cell receptors and corecep-
tors CD8 and CD4 in their recognition of peptide-MHC ligands. Trends Immunol 23:
as PKCθ, while the pSMAC is enriched with adhesion molecules such 408–413, 2002.
129
as LFA-1. The dSMAC contains large glycoproteins such as CD45. In 28. Reith W, Mach B: The bare lymphocyte syndrome and the regulation of MHC expres-
addition to priming of T-cell responses, the immunological synapse is sion. Annu Rev Immunol 19:331–373, 2001.
also important for effector functions. For example, the pSMAC has 29. Artyomov MN, Lis M, Devadas S, et al: CD4 and CD8 binding to MHC molecules pri-
130
marily acts to enhance Lck delivery. Proc Natl Acad Sci U S A 107:16916–16921, 2010.
been suggested to polarize cytotoxic granules released by cytotoxic CD8 30. Ashorn PA, Berger EA, Moss B: Human immunodeficiency virus envelope glycopro-
T cells toward the target cells, therefore preventing the leakage of cyto- tein/CD4-mediated fusion of nonprimate cells with human cells. J Virol 64:2149–2156,
1990.
lytic granule contents to bystander cells, and the cSMAC is implicated 31. Moir S, Chun T-W, Fauci AS: Pathogenic mechanisms of HIV disease. Annu Rev Pathol
as a site for receptor internalization and degradation. 6:223–248, 2011.
32. Schols D: HIV co-receptors as targets for antiviral therapy. Curr Top Med Chem 4:
883–893, 2004.
33. Singer A, Adoro S, Park J-H: Lineage fate and intense debate: Myths, models and mech-
REFERENCES anisms of CD4- versus CD8-lineage choice. Nat Rev Immunol 8:788–801, 2008.
34. Kidd P: Th1/Th2 balance: The hypothesis, its limitations, and implications for health
1. Garcia KC, Teyton L, Wilson IA: Structural basis of T cell recognition. Annu Rev Immunol and disease. Altern Med Rev 8:223–246, 2003.
17:369–397, 1999. 35. Annunziato F, Cosmi L, Galli G, et al: Assessment of chemokine receptor expression by
2. O’Brien RL, Born WK: γδ T cell subsets: A link between TCR and function? Semin human Th1 and Th2 cells in vitro and in vivo. J Leukoc Biol 65:691–699, 1999.
Immunol 22:193–198, 2010. 36. Annunziato F, Galli G, Cosmi L, et al: Molecules associated with human Th1 or Th2
3. Chodaczek G, Papanna V, Zal MA, Zal T: Body-barrier surveillance by epidermal γδ cells. Eur Cytokine Netw 9:12–16, 1998.
TCRs. Nat Immunol 13:272–282, 2012. 37. Bachelerie F, Ben-Baruch A, Burkhardt AM, et al: International Union of Pharmacol-
4. Krangel MS: Mechanics of T cell receptor gene rearrangement. Curr Opin Immunol ogy. LXXXIX. Update on the extended family of chemokine receptors and introducing
21:133–139, 2009. a new nomenclature for atypical chemokine receptors. Pharmacol Rev 66:1–79, 2014.
5. Langerak AW, Groenen PJTA, Bruggemann M, et al: EuroClonality/BIOMED-2 guide- 38. Zhu J, Paul WE: Peripheral CD4+ T-cell differentiation regulated by networks of cytok-
lines for interpretation and reporting of Ig/TCR clonality testing in suspected lymph- ines and transcription factors. Immunol Rev 238:247–262, 2010.
oproliferations. Leukemia 26:2159–2171, 2012. 39. Oestreich KJ, Weinmann AS: Transcriptional mechanisms that regulate T helper 1 cell
6. van der Velden VHJ, Cazzaniga G, Schrauder A, et al: Analysis of minimal residual differentiation. Curr Opin Immunol 24:191–195, 2012.
disease by Ig//TCR gene rearrangements: Guidelines for interpretation of real-time 40. Yagi R, Zhu J, Paul WE: An updated view on transcription factor GATA3-mediated
quantitative PCR data. Leukemia 21:604–611, 2007. regulation of Th1 and Th2 cell differentiation. Int Immunol 23:415–420, 2011.
7. Schrappe M, Valsecchi MG, Bartram CR, et al: Late MRD response determines relapse 41. Maggi E: The TH1/TH2 paradigm in allergy. Immunotechnology 3:233–244, 1998.
risk overall and in subsets of childhood T-cell ALL: Results of the AIEOP-BFM-ALL 42. Allen JE, Sutherland TE: Host protective roles of type 2 immunity: Parasite killing and
2000 study. Blood 118:2077–2084, 2011. tissue repair, flip sides of the same coin. Semin Immunol 26:329–340, 2014.
8. Zinkernagel RM, Doherty PC: Immunological surveillance against altered self com- 43. Schramm G, Haas H: Th2 immune response against Schistosoma mansoni infection.
ponents by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature 251: Microbes Infect 12:881–888, 2010.
547–548, 1974. 44. Singh RP: Immunoregulation of cytokines in infectious diseases (leprosy), future strat-
9. Zinkernagel RM, Doherty PC: Restriction of in vitro T cell-mediated cytotoxicity in egies. Nihon Hansenbyo Gakkai Zasshi 67:263–268, 1998.
lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 45. Lienhardt C, Azzurri A, Amedei A, et al: Active tuberculosis in Africa is associated with
248:701–702, 1974. reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 32:1605–1613, 2002.
10. Garcia KC, Degano M, Stanfield RL, et al: An alphabeta T cell receptor structure at 2.5 46. Galindo CL, Rosenzweig JA, Kirtley ML, Chopra AK: Pathogenesis of Y. enterocolitica
A and its orientation in the TCR-MHC complex. Science 274:209–219, 1996. and Y. pseudotuberculosis in human yersiniosis. J Pathog 2011:16, 2011.
11. Baker BM, Scott DR, Blevins SJ, Hawse WF: Structural and dynamic control of T-cell 47. Steere AC, Drouin EE, Glickstein LJ: Relationship between Immunity to Borrelia burg-
receptor specificity, cross-reactivity, and binding mechanism. Immunol Rev 250:10–31, dorferi outer-surface protein A (OspA) and Lyme arthritis. Clin Infect Dis 52:s259–s265,
2012. 2011.
12. Wang J-H, Reinherz EL: The structural basis of αβ T-lineage immune recognition: TCR 48. D’Elios MM, Amedei A, Benagiano M, et al: Helicobacter pylori, T cells and cytokines:
docking topologies, mechanotransduction, and co-receptor function. Immunol Rev The “dangerous liaisons.” FEMS Immunol Med Microbiol 44:113–119, 2005.
250:102–119, 2012. 49. Vignali DA, Collison LW, Workman CJ: How regulatory T cells work. Nat Rev Immunol
13. Lever M, Maini PK, van der Merwe PA, Dushek O: Phenotypic models of T cell activa- 8:523–532, 2008.
tion. Nat Rev Immunol 14:619–629, 2014. 50. Sakaguchi S, Yamaguchi T, Nomura T, Ono M: Regulatory T cells and immune toler-
14. Barral DC, Brenner MB: CD1 antigen presentation: How it works. Nat Rev Immunol ance. Cell 133:775–787, 2008.
7:929–941, 2007. 51. Rudensky AY: Regulatory T cells and Foxp3. Immunol Rev 241:260–268, 2011.
15. Cohen NR, Garg S, Brenner MB: Antigen presentation by CD1: Lipids, T Cells, and 52. Fu W, Ergun A, Lu T, et al: A multiply redundant genetic switch “locks in” the transcrip-
NKT cells in microbial immunity, in Advances in Immunology, edited by Frederick WA, tional signature of regulatory T cells. Nat Immunol 13:972–980, 2012.
pp 1–94.: Academic Press, 102:1–94, 2009. 53. d’Hennezel E, Bin Dhuban K, Torgerson T, Piccirillo C: The immunogenetics of
16. Ferreira LM: Gammadelta T cells: Innately adaptive immune cells? Int Rev Immunol immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.
32:223–248, 2013. J Med Genet 49:291–302, 2012.
17. Godfrey DI, Rossjohn J, McCluskey J: The fidelity, occasional promiscuity, and versatil- 54. Aaltonen J, Bjorses P, Perheentupa J, et al: An autoimmune disease, APECED, caused
ity of T cell receptor recognition. Immunity 28:304–314, 2008. by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet
18. Norell H, Moretta A, Silva-Santos B, Moretta L: At the bench: Preclinical rationale for 17:399–403, 1997.
exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias. 55. Capalbo D, Giardino G, Martino LD, et al: Genetic basis of altered central tolerance and
J Leukoc Biol 94:1123–1139, 2013. autoimmune diseases: A lesson from AIRE mutations. Int Rev Immunol 31:344–362,
19. Bonneville M, O’Brien RL, Born WK: γδ T cell effector functions: A blend of innate 2012.
programming and acquired plasticity. Nat Rev Immunol 10:467–478, 2010. 56. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY: A function for interleukin 2 in
20. Wucherpfennig KW, Gagnon E, Call MJ, et al: Structural biology of the T-cell receptor: Foxp3-expressing regulatory T cells. Nat Immunol 6:1142–1151, 2005.
Insights into receptor assembly, ligand recognition, and initiation of signaling. Cold 57. Ohkura N, Hamaguchi M, Morikawa H, et al: T cell receptor stimulation-induced
Spring Harb Perspect Biol 2:a005140, 2010. epigenetic changes and Foxp3 expression are independent and complementary events
21. Chakraborty AK, Weiss A: Insights into the initiation of TCR signaling. Nat Immunol required for Treg cell development. Immunity 37:785–799, 2012.
15:798–807, 2014. 58. Abbas AK, Benoist C, Bluestone JA, et al: Regulatory T cells: Recommendations to sim-
22. Guirado M, de Aós I, Orta T, et al: Phosphorylation of the N-terminal and C-terminal plify the nomenclature. Nat Immunol 14:307–308, 2013.
CD3-ε–ITAM tyrosines is differentially regulated in T cells. Biochem Biophys Res Commun 59. Curotto de Lafaille MA, Lafaille JJ: Natural and adaptive Foxp3+ regulatory T cells:
291:574–581, 2002. More of the same or a division of labor? Immunity 30:626–635, 2009.
23. Malissen B, Gregoire C, Malissen M, Roncagalli R: Integrative biology of T cell activa- 60. Veiga-Parga T, Sehrawat S, Rouse BT: Role of regulatory T cells during virus infection.
tion. Nat Immunol 15:790–797, 2014. Immunol Rev 255:182–196, 2013.

Kaushansky_chapter 76_p1175-1188.indd 1186 9/17/15 4:01 PM